Related Experiment Videos
Cell-based models of sustained, interferon-sensitive hepatitis C virus genotype 1 replication
Yoichi Hiasa1, Jason T Blackard, Wenyu Lin
1Gastrointestinal Unit, Massachusetts General Hospital and Harvard Medical School, GRJ 816, 55 Fruit Street, Boston, MA 02114, USA.
Journal of Virological Methods
|November 30, 2005
Summary
New T7 polymerase systems enable sustained hepatitis C virus (HCV) replication in cells, offering improved models for studying HCV pathogenesis and treatment strategies. This research enhances understanding of virus-host interactions.
Area of Science:
- Virology
- Molecular Biology
- Cell Biology
Background:
- Previous studies established hepatitis C virus (HCV) replication using a binary expression system with T7 polymerase.
- Cell toxicity and limited replication duration were observed in earlier models.
Purpose of the Study:
- To develop improved, sustained HCV replication models using replication-defective adenoviral vectors (Ad-T7pol) or T7-expressing cell lines (Huh-T7).
- To investigate the impact of these refined systems on HCV replication dynamics and response to interferon (IFN) treatment.
Main Methods:
- Mammalian cells (CV-1, Huh7, Huh-T7) were transfected with a T7 polymerase-driven HCV cDNA plasmid (pT7-flHCV-Rz).
- Cells were infected with vaccinia-T7 polymerase or treated with Ad-T7pol.
- HCV RNA and protein levels were analyzed over 9 days post-infection.
- The role of NS5B gene expression and IFN treatment on HCV replication was assessed.
Main Results:
- No significant cytotoxicity was observed up to 9 days post-infection.
- HCV RNA (positive- and negative-strand) was detectable throughout the 9-day period, with peak expression days 1-3.
- Efficient HCV replication was dependent on NS5B gene expression.
- IFN treatment significantly reduced HCV positive-strand RNA levels within 1-2 days.
Conclusions:
- Refined binary expression systems provide more durable and authentic models for HCV replication studies.
- These models facilitate the identification of host factors crucial for HCV replication and pathogenesis.
- The systems enable longer-term analysis of virus-host interactions for developing genotype 1 HCV treatments.